Aureus Pharma
extended its knowledge-database agreement with
sanofi-aventis for an additional three-year term. Aureus will provide new
AurSCOPE® knowledge databases and continue to update existing databases for sanofi-aventis’ R&D division.
Aureus’ databases will give sanofi-aventis researchers access to information on therapeutic targets including GPCR protein receptors, nuclear receptors, kinase inhibitors, and ion channels as well as drug-safety data.